Rchr
J-GLOBAL ID：201901010576074337
Update date: Jan. 31, 2024
Fujioka Yohei
フジオカ ヨウヘイ | Fujioka Yohei
Affiliation and department：
Research field (1)：
Metabolism and endocrinology
Research theme for competitive and other funds (3)：
- 2019 - 2022 Research for the novel therapeutic target of insulin resistance and type 2 diabetes by analyzing of exosome
- 2018 - 2020 Clinical and direct effects of FABP4 on insulin resistance and secretion
- 2014 - 2016 a novel insulin resistance index for the patients with type 2 diabetes
Papers (108)：
-
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Yuichi Ito, Sonoko Kitao, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Hiroko Okura, Kazuhiko Matsuzawa, et al. Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report. Diabetology & Metabolic Syndrome. 2022. 14. 1
-
Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Sonoko Kitao, Yuichi Ito, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Kazuhiko Matsuzawa, Shoichiro Izawa, et al. The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes. Scientific Reports. 2022. 12. 1
-
阿武 茉利, 藤岡 洋平, 高橋 雅子, 伊藤 祐一, 庄司 恭子, 角 啓佑, 松澤 和彦, 伊澤 正一郎, 谷口 晋一, 山本 一博. Dulaglutide導入後の悪心に関連する因子についての検討. 糖尿病. 2022. 65. 11. 626-626
-
阿武 茉利, 伊澤 正一郎, 藤岡 洋平, 松澤 和彦, 齋藤 洸平, 引田 克弥, 牧島 かれん, 野坂 香苗, 堀江 靖, 武中 篤, et al. VHL遺伝子の体細胞変異を基盤に発症した腹部paragangliomaの1例. 日本内分泌学会雑誌. 2021. 97. Suppl.Update. 81-83
-
阿武 茉利, 伊澤 正一郎, 藤岡 洋平, 松澤 和彦, 齋藤 洸平, 引田 克弥, 牧島 かれん, 野坂 香苗, 堀江 靖, 武中 篤, et al. VHL遺伝子の体細胞変異を基盤に発症した腹部paragangliomaの1例. 日本内分泌学会雑誌. 2021. 97. Suppl.Update. 81-83
ｍore...
MISC (22)：
-
庄司 恭子, 大倉 毅, 太田 友樹, 小倉 有李子, 阿武 茉利, 有馬 那帆, 北尾 苑子, 伊藤 祐一, 松本 和久, 中村 理沙, et al. 糖尿病治療自己中断歴と東大式エゴグラムの関連についての検討. 糖尿病. 2018. 61. Suppl.1. S-167
-
Tsuyoshi Okura, Kei Teramoto, Rie Koshitani, Sonoko Kawamoto, Yuichi Ito, Yohei Fujioka, Keisuke Sumi, Kyoko Shoji, Risa Nakamura, Kazuhisa Matsumoto, et al. The Glucose Monitoring System Reduces the Incidents of Glucose Measurement. DIABETES. 2017. 66. A237-A237
-
Tsuyoshi Okura, Youhei Fujioka, Risa Nakanishi, Hideki Shiochi, Keisuke Sumi, Kyoko Shoji, Ayumi Murawaki, Kazuhiko Matsuzawa, Schoichiro Izawa, Chieko Sakai, et al. 20/(Fasting C-Peptide x Fasting Plasma Glucose) Is a Novel Index of Insulin Resistance with Small Effect of Hepatic Insulin Clearance. DIABETES. 2015. 64. A496-A496
-
Y. Fujioka, T. Ohkura, K. Shoji, K. Sumi, H. Shiochi, N. Yamamoto, K. Matsuzawa, A. Murawaki, S. Izawa, H. Ohkura, et al. Normal meal tolerance test is more valuable than glucagon stimulation test in type 2 diabetes. DIABETOLOGIA. 2014. 57. S210-S210
-
Shoichiro Izawa, Kazuhiko Matsuzawa, Keisuke Sumi, Youhei Fujioka, Naoya Yamamoto, Hideki Shiochi, Risa Nakanishi, Tsuyoshi Ohkura, Hiroko Ohkura, Masahiko Kato, et al. Preoperative Management of I-123-Metaiodobenzylguanidine Positive Tumors Mimicking Pheochromocytoma. ENDOCRINE REVIEWS. 2014. 35. 3
ｍore...
Education (2)：
- 2008 - 2012 Tottori University Faculty of Medicine
- 2000 - 2007 Tottori University Faculty of Medicine School of Medicine
Return to Previous Page
